OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 20, 2022
Regulatory officials are addressing challenges in ensuring that clinical data can be relied on in making regulatory decisions.
June 08, 2022
One can use modeling methods to generate data and shorten development timelines in preclinical studies.
June 02, 2022
Having a clear clinical strategy early on can shave time off overall development projects.
May 01, 2022
Applying modeling methods in preclinical studies can be a powerful tool for generating data and shortening development timelines.
April 20, 2022
New guidance from FDA and legislation from Congress promote clinical trial diversity.
April 01, 2022
Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.
March 25, 2022
Huma has acquired AstraZeneca’s digital health platform, and AstraZeneca has become a shareholder of Huma in a partnership to accelerate digital-first patient care.
March 01, 2022
Optimizing the use of partners for clinical trials depends on selecting the right contractor.
Capacity concerns and regulatory compliance considerations will drive the decision about outsourcing the manufacture of clinical trial materials.
November 15, 2021
Under the expanded agreement with Agios, Centogene will provide global clinical trial support for thalassemia and sickle cell diseases.